Published in Women's Health Weekly, November 22nd, 1999
The clinical findings indicate that patients who undergo tumor excision within the follicular phase (day 3-day 12) of their menstrual cycle experience significantly impaired chances for survival, in comparison with patients who undergo surgery during alternate phases of their menstrual cycle (the luteal phase).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly